StemBioSys Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:StemBioSys Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013517
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
StemBioSys Inc (StemBioSys) is a biomedical company that concentrates on isolation, expansion and delivery of specialized adult stem cells. The company has developed high performance microenvironment for treating human diseases. Its HPME is an advanced stem cell culture system that creates natural environment and replicates a 3-dimensional microenvironment which allows stem cells more rapidly with greater preservation of stem cell phenotype than traditional ones. The company’s target therapy areas include diabetes, Parkinson’s disease, Alzheimer’s disease, osteoarthritis, inflammatory disorders and damaged cartilage. StemBioSys is headquartered in San Antonio, Texas, the US.

StemBioSys Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
StemBioSys Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
StemBioSys Inc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
StemBioSys Raises USD2.7 Million in Venture Financing 10
StemBioSys Raises USD8 Million in Series A Financing 11
StemBioSys Raises US$4.4 Million In Venture Financing 12
Partnerships 13
StemBioSys Enters into Distribution Agreement with SeouLin Bioscience 13
Gencure Enters into Agreement with StemBioSys 14
Cellular Dynamics Enters into Distribution Agreement with Seoulin Bioscience 15
StemBioSys Partners with Cardiovate 16
Licensing Agreements 17
StemBioSys Enters into Licensing Agreement with South Texas Technology Management 17
StemBioSys Inc – Key Competitors 18
StemBioSys Inc – Key Employees 19
StemBioSys Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Recent Developments 21
Government and Public Interest 21
Oct 03, 2016: BioBridge Global-Led Biotech team Awarded $7.8 Million MTEC Contract 21
Other Significant Developments 23
Jan 18, 2017: StemBioSys Announces US and Canadian Distribution Agreement with VWR 23
Aug 02, 2016: Diamyd Medical’s associated company Cellaviva is appointed European distributor for StemBioSys 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List of Tables
StemBioSys Inc, Pharmaceuticals & Healthcare, Key Facts 2
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
StemBioSys Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
StemBioSys Inc, Deals By Therapy Area, 2011 to YTD 2017 8
StemBioSys Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
StemBioSys Raises USD2.7 Million in Venture Financing 10
StemBioSys Raises USD8 Million in Series A Financing 11
StemBioSys Raises US$4.4 Million In Venture Financing 12
StemBioSys Enters into Distribution Agreement with SeouLin Bioscience 13
Gencure Enters into Agreement with StemBioSys 14
Cellular Dynamics Enters into Distribution Agreement with Seoulin Bioscience 15
StemBioSys Partners with Cardiovate 16
StemBioSys Enters into Licensing Agreement with South Texas Technology Management 17
StemBioSys Inc, Key Competitors 18
StemBioSys Inc, Key Employees 19
StemBioSys Inc, Other Locations 20
StemBioSys Inc, Subsidiaries 20

★海外企業調査レポート[StemBioSys Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • V. F. Corporation:企業の戦略・SWOT・財務情報
    V. F. Corporation - Strategy, SWOT and Corporate Finance Report Summary V. F. Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Bial – Portela & Ca SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Bial - Portela & Ca SA (BIAL) is a pharmaceutical company that discovers, develops and provides drugs for neurosciences and cardiovascular therapeutic areas. The company offers products such as anti-inflammatories, anti-diabetics, cardiovascular, anti-asthmatics, antibiotics, antidepressants …
  • Park Hotels & Resorts Inc (PK):企業の財務・戦略的SWOT分析
    Park Hotels & Resorts Inc (PK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Matthews International Corp (MATW):企業の財務・戦略的SWOT分析
    Matthews International Corp (MATW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • T2 Biosystems Inc (TTOO):企業の財務・戦略的SWOT分析
    Summary T2 Biosystems Inc (T2 Biosystems) is a provider of clinical diagnostic products in the field of in vitro diagnostics. The company’s T2 magnetic resonance technology allows direct detection in complex samples such as whole blood, serum, plasma, sputum and urine. It offers T2HemoStat panel, T2 …
  • C-Rad AB (CRAD B):企業の財務・戦略的SWOT分析
    Summary C-Rad AB (C-Rad) is a medical device company that develops, manufactures and markets advanced radiation therapy equipments . The company offers products and solutions for patient positioning, tumor localization, and radiation treatment systems . Its products include sentinel 4DCT, catalyst H …
  • ULURU Inc (ULUR)-医療機器分野:企業M&A・提携分析
    Summary ULURU Inc (ULURU) is a developer and commercializer of wound care and muco-adhesive film products. The company’s products include Altrazeal and OraDisc. Its Altrazeal is a transforming powder dressing with Nanoflex technology for the management of exuding wounds. ULURU’s OraDisc is a polymer …
  • BlueScope Steel Ltd:企業のM&A・事業提携・投資動向
    BlueScope Steel Ltd - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's BlueScope Steel Ltd Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Perrigo Company Plc (PRGO):医療機器:M&Aディール及び事業提携情報
    Summary Perrigo Company plc (Perrigo) is an over-the-counter consumer goods and specialty pharmaceutical company. It develops, manufactures and distributes over-the-counter products, generic and prescription pharmaceuticals, specialty pharmaceutical company, nutritional products, active pharmaceutic …
  • DaVita Inc.:戦略・SWOT・企業財務分析
    DaVita Inc. - Strategy, SWOT and Corporate Finance Report Summary DaVita Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Bancolombia SA (BCOLOMBIA):企業の財務・戦略的SWOT分析
    Bancolombia SA (BCOLOMBIA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • AstraZeneca PLC:企業のM&A・事業提携・投資動向
    AstraZeneca PLC - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AstraZeneca PLC Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestm …
  • Brightside Group:企業の戦略・SWOT・財務情報
    Brightside Group - Strategy, SWOT and Corporate Finance Report Summary Brightside Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • America’s Car-Mart, Inc. (CRMT):企業の財務・戦略的SWOT分析
    America's Car-Mart, Inc. (CRMT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • Awarepoint Corp-医療機器分野:企業M&A・提携分析
    Summary Awarepoint Corp (Awarepoint) is a healthcare technology company that offers real time location system. The company provides technology, software and managed services. It offers location software packages for mobile phones and other electronics. Awarepoint’s software packages provide patient …
  • Burns & McDonnell:企業の戦略・SWOT・財務情報
    Burns & McDonnell - Strategy, SWOT and Corporate Finance Report Summary Burns & McDonnell - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Wanhua Chemical Group Co Ltd (600309):企業の財務・戦略的SWOT分析
    Wanhua Chemical Group Co Ltd (600309) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Interseguro Compania de Seguros SA:企業の戦略・SWOT・財務分析
    Interseguro Compania de Seguros SA - Strategy, SWOT and Corporate Finance Report Summary Interseguro Compania de Seguros SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Rafako SA (RFK):企業の財務・戦略的SWOT分析
    Rafako SA (RFK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • MegaChips Corporation (6875):企業の財務・戦略的SWOT分析
    MegaChips Corporation (6875) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆